The 30-bp deletion variant of Epstein-Barr virus-encoded latent membrane protein-1 prevails in acute infectious mononucleosis

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1370-1373

  Berger, Christoph ^b   McQuain, Cathy ^b   Sullivan, John L ^b   Nadal, David ^b   Quesenberry, Peter J ^b   Knecht, Hans ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; B CELL LYMPHOMA; CARBOXY TERMINAL SEQUENCE; CHILD; CLINICAL ARTICLE; DELETION MUTANT; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTIOUS MONONUCLEOSIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN VARIANT; SEQUENCE ANALYSIS; SWITZERLAND; TONSIL DISEASE; UNITED STATES;

EID: 0030730830     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517324     Document Type: Article

References (15)

1. Rickinson AB, Kieff E. Epstein-Barr virus. Fields BN, Knipe DM, Howley PM, et al., eds. Virology. Philadelphia: Lippincott-Raven, 1996:2397-446.
2. Mitchell T, Sugden B. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J Virol 1995;69:2968-76.
3. Santon A, Manzanal AI, Campo E, Bellas C. Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. J Clin Pathol Mol Pathol 1995;48:M184-7.
4. Knecht H, Raphael M, McQuain C, et al. Deletion variants within the NF-κB activation domain of the LMP1 oncogene prevail in AIDS-related large cell lymphomas and HIV-negative atypical lymphoproliferation. Blood 1996;87:876-81.
5. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996;88:242-51.
6. Hu LF, Zabarovsky ER, Chen F, et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991;72:2399-409.
7. Li SN, Chang YS, Liu ST. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 1996;12:2129-35.
8. Sandvej K, Gratama J, Hamilton-Dutoit S. Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild type EBV isolates [abstract E8.2]. In: Program and abstracts of the 7th international EBV symposium (Hong Kong). Chapel Hill, NC: International Association for Epstein-Barr Virus Research, 1996.
9. Khanim F, Yao QY, Niedobitek G, Sihota S, Rickinson AB, Young LS. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996;88:3491-501.
10. Chen WC, Chen YY, Bacchi MM, Bacchi CE, Alvarenga M, Weiss LM. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Am J Pathol 1996;148:17-23.
11. Chen ML, Tsai CN, Liang CL, et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992;7:2131-40.
12. Trivedi P, Hu LF, Chen F, et al. Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. Eur J Cancer 1994;30A:84-8.
13. Walling DM, Clark NM, Markovitz DM, et al. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J Infect Dis 1995;171:1122-30.
14. Palefsky JM, Berline J, Penaranda ME, Lennette ET, Greenspan D, Greenspan JS. Sequence variation of latent membrane protein-1 of Epstein-Barr virus strains associated with hairy leukoplakia. J Infect Dis 1996;173:710-4.
15. Liu YJ, Malisan F, de Bouteiller O, et al. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 1996;4:241-50.